News
Common analgesic gas aids in opening of blood-brain barrier
Nitrous oxide, a commonly used analgesic gas, improved temporary opening of the blood-brain barrier (BBB) and gene therapy delivery in mouse models using focused ultrasound (FUS), UT Southwestern Medical Center researchers report in a new study.
Protein linked to immunotherapy resistance in kidney cancer
A protein identified by researchers at UT Southwestern Medical Center may drive resistance to immune checkpoint inhibitors, a widely used form of immunotherapy to treat cancer.
UT Southwestern and Children’s Health receive record-setting gift from Moody Foundation
UT Southwestern Medical Center and Children’s Health℠ today announced a historic nine-figure grant from the Moody Foundation to support the new $5 billion pediatric campus in Dallas, which broke ground in October 2024. The new hospital will help meet the increasing demand for pediatric health care, research and training. The Moody Foundation’s transformational grant is the largest gift to date for this landmark project.
Growing number of U.S. adolescents receive weight-loss surgery
Weight-loss surgeries for adolescents increased 15% in the U.S. between 2021 and 2023, even as the Food and Drug Administration (FDA) approved effective new weight-loss medications for this age group, a study led by UT Southwestern Medical Center researchers shows. Their findings, published in The Journal of Pediatrics, shed light on how severe obesity is being treated in teenagers, the fastest growing age group with this condition.
Differences in survival persist despite access to cancer clinical trials
Black and Hispanic children with high-risk neuroblastoma experience worse survival outcomes than their white peers, even when treated in frontline clinical trials, according to a study led by a UT Southwestern Medical Center researcher.
Artificial intelligence predicts kidney cancer therapy response
An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict which kidney cancer patients will benefit from anti-angiogenic therapy, a class of treatments that’s only effective in some cases.
Immune protein STING key for repairing, generating lysosomes
– The STING protein, known for helping cells fight viral infections by generating inflammation, also appears to function as a quality control sensor for organelles that serve as cellular waste disposal systems, UT Southwestern Medical Center researchers found. Their study, published in Molecular Cell, helps explain critical features of diseases called lysosomal storage disorders and could eventually lead to new treatments for these and other neurodegenerative diseases.
Grant worth up to $5 million aids research for cerebellar disorders
A multidisciplinary team of UT Southwestern Medical Center specialists, led by Nader Pouratian, M.D., Ph.D., and Peter Tsai, M.D., Ph.D., has received a grant worth up to $5 million from the Raynor Cerebellum Project to develop neuromodulation therapies for patients with cerebellar disorders of the brain.
UT Southwestern Q&A: What you need to know about the measles
The outbreak of measles that started in West Texas in January and spread to other regions and states has focused renewed attention on a childhood disease that had been eliminated in the United States in recent decades.
The perfect match: UTSW students open envelopes to residency futures
Members of UT Southwestern Medical School’s Class of 2025 gathered with anticipation inside the Bryan Williams, M.D., Student Center gymnasium Friday morning to learn where they will begin the next phase of their training as residents.